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Hemodialysis-associated hypotension as an independent risk
factor for two-year mortality in hemodialysis patients.
Background. The relationship between blood pressure (BP)
and mortality in hemodialysis patients has remained controver-
sial. Some studies suggested that a lower pre- or postdialysis
BP was associated with excess mortality, while others showed
poorer outcome in patients with uncontrolled hypertension.
We conducted a multicenter prospective cohort study to eval-
uate the impact of hemodialysis-associated hypotension on
mortality.
Methods. We recruited 1244 patients (685 males; mean age,
60 ± 13 years) who underwent hemodialysis in 28 units during
the two-year study period beginning in December 1999. Pre-,
intra-, and postdialysis BP, and BP upon standing soon after
hemodialysis, were measured in all patients at entry. Logistic
regression analysis was used to assess the effect on mortality of
pre-, intra-, and postdialysis BP, a fall in BP during hemodialysis,
and a fall in BP upon standing soon after hemodialysis.
Results. During the study period, 149 patients died. Logistic
models identified the lowest intradialysis systolic blood pres-
sure (SBP) and degree of fall in SBP upon standing soon after
hemodialysis as significant factors affecting mortality, but not
pre- or postdialysis SBP and diastolic BP. The adjusted odds
ratio for death was 0.79 (95% CI 0.64–0.98) when the lowest
intradialysis SBP was analyzed in increments of 20 mm Hg, and
was 0.82 (95% CI 0.67–0.98) when the fall in SBP upon standing
soon after hemodialysis was analyzed in increments of 10 mm
Hg.
Conclusion. These results suggest that intradialysis
hypotension and orthostatic hypotension after hemodialysis
are significant and independent factors affecting mortality in
hemodialysis patients.
The relationship between blood pressure (BP) and sur-
vival in hemodialysis patients has remained quite contro-
versial. Hypertension is considered the most important
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risk factor for the development of cardiovascular compli-
cations that are the main cause of morbidity and mortality
in hemodialysis patients [1]. Charra et al [2] reported that
survival of hemodialysis patients was markedly poorer
in patients with mean arterial pressure above 99 mm
Hg, but these data were not adjusted for confounders.
In contrast, recent studies have shown that lower BP is
associated with excess mortality. In a study of 1243 pa-
tients in Okinawa, Iseki et al [3] found that low diastolic
blood pressure (DBP) was associated with a higher death
rate. Zager et al [4] advocated a U-shaped association be-
tween postdialysis BP and mortality, with increased mor-
tality for systolic blood pressure (SBP) >180 mm Hg and
<110 mm Hg. They found that low SBP was associated
with increased mortality, pre- and postdialysis, in 5433
hemodialysis patients. Port et al [5] also confirmed the
association of low predialysis SBP with increased mortal-
ity after adjustment for confounders in 4499 hemodialy-
sis patients. One potential confounding factor could be
hemodialysis-associated hypotension [6, 7]. While it is
plausible that hemodialysis-associated hypotension in-
creases mortality, little data are available. Koch et al [8]
reported that among 196 dialyzed diabetic patients, a
greater proportion of those dying from myocardial infarc-
tion had repetitive severe hypotension during hemodial-
ysis. However, their study failed to show a significant
difference in BP during hemodialysis between patients
with lethal myocardial infarction and survivors.
We hypothesized that hemodialysis-associated hy-
potension increases mortality. To test this hypothesis, we
conducted a multicenter prospective, observational co-
hort study named the Nakanoshima study, which had a
follow-up period of two years and included more than
1200 hemodialysis patients.
METHODS
Study design and subjects
The Nakanoshima study was initiated in December
1999, and the target study population was 1381 Japanese
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patients who were undergoing maintenance hemodialysis
at 28 hemodialysis units. Inclusion criteria were patients
already undergoing dialysis in December 1999 and those
who had regularly scheduled hemodialysis two or three
times a week at an out- or in-patient facility. Patients
who were receiving hemofiltration or hemodiafiltration
were excluded from the study. Eligible for study were
1244 patients with complete data on gender, diabetes sta-
tus, body mass index, and body weight. Baseline BP was
recorded within a single hemodialysis session that was the
first session of the week. The major evaluation variable
was hemodialysis-associated hypotension, namely, intra-
dialysis hypotension and orthostatic hypotension occur-
ring soon after hemodialysis. We analyzed the BP and
pulse rate measured at five points: (1) before hemodialy-
sis with the patient upright; (2) before hemodialysis with
the patient supine (BP measured within five minutes after
assuming supine position); (3) during dialysis (the lowest
intradialysis BP); (4) after hemodialysis with the patient
supine (BP measured just before detachment of dialysis
circuit from patient); and (5) soon after hemodialysis with
the patient standing (BP measured within five minutes of
standing following detachment of dialysis circuit). Pulse
pressure was calculated from SBP and DBP (pulse pres-
sure = SBP − DBP). Hematocrit (Hct) was measured
before and after hemodialysis on the same day.
Other measurements
From the data files originally prepared by the 28 dialy-
sis units for the annual survey of the Japanese Society for
Dialysis Therapy [9], data were extracted for the follow-
ing covariates: age, gender, years on hemodialysis, pri-
mary cause of death, serum albumin, serum creatinine,
Hct before and after hemodialysis, dialysis dose (Kt/V),
interdialysis body weight gain, body weight before and
after hemodialysis, number of hemodialysis sessions a
week, hours of hemodialysis, and use of antihypertensive
or antihypotensive medications. Blood sampling was per-
formed in the same month as the measurement of BP. The
data files were obtained directly from the 28 hemodialysis
units. The numbers of missing values were as follows: 340
(28.2%) for Kt/V, 359 (29.8%) for protein catabolic rate,
360 (29.9%) for serum albumin, and 241 (20.0%) for C-
reactive protein. The intradialysis decrease in blood vol-
ume (dBV) was calculated as a fraction of the predialysis
value by the following equation:
dBV = (BVpre − BVpost)/BVpre
= (Hctpost − Hctpre)/Hctpost
Follow-up
Patients were followed until December 31, 2001. The
primary end point was death. Dates and causes of death
were obtained from reports of the 28 hemodialysis units.
For patients transferred to other hemodialysis units, we
reviewed the questionnaires filled out by attending physi-
cians at those units.
Statistical analysis
Continuous variables were compared using Student
t test. Pearson’s product-moment correlation coefficient
(r) was used to determine the relationship between a de-
crease in BP and age, duration of hemodialysis, intra-
dialysis decrease in body weight, ultrafiltration per body
weight, intradialysis decrease in blood volume, body mass
index, or serum albumin. The effects of pre-, intra-, and
postdialysis SBP, DBP, and pulse pressure on death rates
were analyzed using univariate and multivariate logis-
tic regression models. BP was analyzed in increments of
10 mm Hg in each model, with the exception of SBP in
the multivariate logistic regression model, which was an-
alyzed in increments of 20 mm Hg. The BP associated
with the lowest mortality was selected as the reference
value, and assigned an odds ratio of 1.0. The multivari-
ate models were adjusted for age, gender, diabetes sta-
tus, serum creatinine, ultrafiltration per body weight, and
body weight after hemodialysis. These adjustment fac-
tors were selected based on the facts that they are known
prognostic factors, or that they affected mortality signifi-
cantly in this study as shown in the univariate study. How-
ever, Kt/V, protein catabolic rate, serum albumin, and C-
reactive protein were excluded from multivariate analysis
because of missing values as described above. A P value
(two-tailed) less than 0.05 was regarded to indicate sig-
nificance. Calculations were performed using SPSS 11.0.1
for Windows (SPSS, Inc., Chicago, IL, USA).
RESULTS
Patient characteristics and two-year mortality
Of the 1244 patients, 38 were censored during the two-
year observation period because of kidney transplanta-
tion, transfer to another hemodialysis unit, or loss to
follow-up. Ultimately, 1206 patients were evaluable. Dur-
ing the two-year follow-up, 149 patients died, with a death
rate of 6.2% per year. The 149 deaths during the follow-
up included 77 fatal cardiovascular or cerebrovascular
events: 22 deaths attributable to acute myocardial infarc-
tion, 13 to congestive heart failure, 12 to noncongestive
heart failure, 12 to cerebral hemorrhage, 6 to cerebral
infarction, 2 to stroke (failed to distinguish between
hemorrhage or infarction), 8 to sudden death, and 2 to
pulmonary infarction. Sudden death was defined as a
witnessed death that occurred within one hour after the
onset of acute symptoms, with no evidence of accident or
violence. There were 69 noncardiovascular or noncere-
brovascular deaths: 20 deaths attributable to malignancy,
20 to infection, 3 to liver cirrhosis, 3 to gastrointestinal
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Table 1. Characteristics of the hemodialysis study cohort
Survivors Fatalities
Variable (N = 1057) (N = 149)
Gender (male/female) 585/472 86/63
Age years 58.8 (12.5) 67.6 (11.8)a
Diabetes mellitus % 23.8 35.1a
Kt/V 1.29 (0.35) 1.17 (0.28)a
Body mass index kg/m2 20.9 (3.3) 20.7 (3.3)
Body weight after hemodialysis kg 53.1 (10.1) 50.0 (9.8)a
Inter-dialysis body weight gain kg 2.5 (1.0) 2.3 (1.1)
Ultrafiltration per body weight mL/kg 47.7 (18.9) 46.4 (18.9)
dBV % 10.0 (7.3) 8.1 (8.0)a
Serum creatinine mg/dL 11.7 (2.8) 9.6 (2.8)a
Serum albumin g/dL 3.8 (0.4) 3.5 (0.5)a
Hemodialysis per week times 3.0 (0.2) 3.0 (0.3)
Hemodialysis time min/session 239.0 (22.7) 235.8 (28.1)
Duration of hemodialysis years 7.1 (5.6) 6.7 (5.8)
dBV, decrease in blood volume. Values are expressed as mean (SD), or
number.
a P < 0.05 in survivors vs. fatalities.
bleeding, 3 to malnutrition, 2 to ischemic colitis, 2 to ac-
cident, 1 to hyperkalemia, 1 to fulminant hepatitis, and
14 to other causes. The cause of death in 3 patients was
unknown.
Table 1 summarizes the baseline characteristics of the
study cohort. Compared to survivors, the patients who
died had significantly higher age, higher percentage of di-
abetes, lower body weight after hemodialysis, lower de-
crease in blood volume, lower serum creatinine before
hemodialysis, and lower serum albumin. The ultrafiltra-
tion rate adjusted for body weight did not differ between
the two groups. Although the number of hemodialysis
sessions per week and dialysis time per session was not
significantly different between the two groups, Kt/V was
significantly lower in the patients who died. Bicarbonate
solution was used as the dialysate in all patients. Reuse
of dialyzers is not permitted in Japan.
Blood pressure during hemodialysis
Figure 1A shows mean ± SD changes in SBP mea-
sured during one hemodialysis session in subjects who
died versus those who survived. The lowest intradialy-
sis SBP was significantly lower in the patients who died,
as was the SBP upon standing soon after hemodialysis.
The DBP was significantly lower in the patients who died
at all points (Fig. 1B). The mean falls in SBP and DBP
from the supine BP measured before hemodialysis to
the lowest intradialysis BP were 28.2 ± 23.6 and 6.5 ±
11.8 mm Hg, respectively. The mean falls in SBP and DBP
upon standing soon after hemodialysis from the supine
BP measured after hemodialysis were 16.8 ± 23.9 and
4.6 ± 13.7 mm Hg, respectively. There were no significant
differences in the magnitude of the average absolute (in
mm Hg) BP decrease during hemodialysis between pa-
tients who died and those who survived.
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Fig. 1. Mean (±SD) changes of blood pressure during hemodialysis
(HD) in survivors and fatalities in December 1999. Systolic blood pres-
sure (A), diastolic blood pressure (B).
Factors affecting hemodialysis-associated hypotension
As shown in Table 2, duration of hemodialysis, inter-
dialysis body weight gain, ultrafiltration rate adjusted for
body weight, dBV, and serum albumin values correlated
significantly with fall in SBP from the supine value be-
fore hemodialysis to the lowest intradialysis value, while
duration of dialysis correlated significantly with fall in
DBP. Similarly, these parameters, except serum albu-
min values, significantly correlated with fall in SBP upon
standing soon after hemodialysis from the supine value
measured after hemodialysis, while duration of dialysis
and dBV correlated significantly with fall in DBP. In di-
abetic patients, the fall in SBP from the supine value be-
fore hemodialysis to the lowest intradialysis value was
significantly greater than in nondiabetic patients. In ad-
dition, falls in both SBP and DBP upon standing soon
after hemodialysis from the supine value measured after
hemodialysis were significantly greater than in nondia-
betic patients.
Predictors of two-year mortality by univariate
logistic regression analysis
Univariate logistic regression analysis was used to eval-
uate the association of two-year mortality with clinical
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Table 2. Factors affecting fall in intra- or postdialysis blood pressures
Intradialysis lowest Postdialysis standing
Fall in SBP Fall in DBP Fall in SBP Fall in DBP
R P valuea R P valuea R P valuea R P valuea
Age years 0.048 0.103 0.002 0.941 0.049 0.100 0.017 0.577
Duration of hemodialysis years 0.099 0.002 0.118 <0.001 −0.127 <0.001 −0.091 0.005
Interdialytic body weight gain kg 0.115 <0.001 0.035 0.284 0.085 0.008 0.042 0.208
Ultrafiltration per body weight L/kg 0.135 <0.001 0.043 0.221 0.095 0.005 0.036 0.299
dBV % 0.136 <0.001 0.028 0.401 0.115 <0.001 0.109 0.001
Body mas index kg/m2 0.064 0.109 0.031 0.453 −0.002 0.969 −0.017 0.675
Serum albumin g/dL 0.100 0.004 0.001 0.974 −0.016 0.640 −0.067 0.061
Fall in SBP Fall in DBP Fall in SBP Fall in DBP
Mean SD Mean SD Mean SD Mean SD
Gender
Female 30.8 24.7 7.8 12.0 15.0 21.7 3.4 13.8
Male 25.8 22.2 5.4 11.4 17.8 24.8 5.2 13.1
P valueb 0.001 0.327 0.058 0.034
Primary disease
Nondiabetes mellitus 25.5 20.9 6.2 11.7 13.9 23.1 3.2 13.9
Diabetes mellitus 34.4 29.6 6.5 11.8 26.2 25.1 8.9 13.7
P valuec <0.001 0.087 <0.001 <0.001
Abbreviations are: R, Pearson’s product-moment correlation coefficient (r); SBP, systolic blood pressure; DBP, diastolic blood pressure; dBV, decrease in blood
volume.
aP value is for the corresponding correlations.
bP value is female vs. male.
cP value is nondiabetes mellitus vs. diabetes mellitus.
parameters (Table 3). Significant univariate predictors
of two-year mortality were age, presence of diabetes
mellitus, Kt/V, protein catabolic rate, body weight after
hemodialysis, dBV, serum creatinine before hemodialy-
sis, increase in Hct, serum albumin, and C-reactive pro-
tein values. Interdialysis body weight gain tended to
predict two-year mortality with borderline significance.
Other variables, including gender, body mass index, ul-
trafiltration rate adjusted for body weight, Hct before or
after hemodialysis, and duration of hemodialysis did not
relate significantly with two-year mortality.
Intradialysis hypotension and two-year mortality
Figure 2 demonstrates the relationships of the predial-
ysis BP and the fall in BP during hemodialysis with death.
A greater fall in SBP was associated with increased mor-
tality for all the predialysis SBP ranges (Fig. 2A). This
relationship was most clearly demonstrated when the
cut-off point for the fall in SBP was set at 40 mm Hg
(greater fall: 40 mm Hg or greater, smaller fall: less than
39 mm Hg). The impact of the intradialysis fall in SBP
on mortality was independent of the predialysis SBP. In
patients with a predialysis DBP lower than 69 mm Hg, a
greater fall in DBP was associated with increased mortal-
ity (Fig. 2B). This relationship was most clearly demon-
strated when the cut-off point for the fall in DBP was set
at 10 mm Hg (greater fall: 10 mm Hg or greater, smaller
fall: less than 9 mm Hg). Figure 3 shows the two-year mor-
tality according to the lowest intradialysis BP. A lower BP
was associated with increased mortality.
Table 3. Univariate association between individual covariates and
two-year mortality by the logistic regression model
Variable Odds ratio (95% CI) P value
Gender male 0.83 (0.45–1.53) 0.552
Age years 1.07 (1.05–1.08) <0.001
Diabetes mellitus
Presence vs. absence 1.73 (1.18–2.55) 0.005
Kt/V 0.28 (0.14–0.59) 0.001
Protein catabolic rate g/kg/day 0.98 (0.97–0.99) 0.012
Body mass index kg/m2 0.98 (0.88–1.09) 0.650
Body weight after hemodialysis kg 0.97 (0.95–0.99) 0.003
Inter-dialytic body weight gain kg 0.83 (0.69–1.00) 0.052
Ultrafiltration per body weight L/kg 0.96 (0.87–1.08) 0.516
dBV % 0.37 (0.003–0.53) 0.015
Serum creatinine mg/dL 0.77 (0.72–0.83) <0.001
Hematocrit before dialysis % 1.03 (0.98–1.08) 0.294
Hematocrit after dialysis % 0.98 (0.94–1.02) 0.291
Increase in hematocrit % 0.91 (0.85–0.98) 0.017
Serum albumin g/dL 0.21 (0.12–0.36) <0.001
C-reactive protein mg/dL 1.24 (1.08–1.42) 0.002
Duration of hemodialysis years 0.99 (0.95–1.02) 0.440
We examined the relationship between the lowest in-
tradialysis BP and mortality using multivariate logistic
regression analysis. After adjustment for known prog-
nostic factors, the odds ratio for SBP between 110 and
119 mm Hg remained significantly associated with mor-
tality, as did the odds ratio for DBP lower than 59 mm Hg
(Table 4). After precluding accidental death unrelated to
hemodialysis or uremia, both the odds ratio for SBP be-
tween 110 and 119 mm Hg and that for DBP lower than
59 mm Hg remained significantly associated with mor-
tality. To analyze the impact of hemodialysis-associated
1216 Shoji et al: Hemodialysis-associated hypotension and mortality
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Fig. 2. Two-year mortalities for various
ranges of predialytic blood pressure and
fall in blood pressure during hemodialysis.
Within each range of predialytic blood
pressure, the columns indicate two-year
mortality associated with falls in blood
pressure during hemodialysis in two groups.
Cut-offs for grouping are defined at the top
of (A) and (B). (A) shows systolic blood
pressure (SBP) and (B) shows diastolic blood
pressure (DBP). A greater fall in SBP is
associated with increased mortality in all
ranges of predialysis SBP.
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Fig. 3. Two-year mortality associated with in-
tradialysis blood pressure. Lower blood pres-
sure is associated with increased mortality. (A)
shows systolic blood pressure, and (B) shows
diastolic blood pressure. SBP, systolic blood
pressure; DBP, diastolic blood pressure.
hypotension on cardiovascular and cerebrovascular dis-
eases, we examined the relationship between the lowest
intradialysis BP and cardio/cerebrovascular death rate
using multivariate logistic regression analysis. As shown
in Table 4, the odds ratio for DBP lower than 59 mm Hg
remained significantly associated with mortality.
Orthostatic hypotension occurring soon after
hemodialysis and two-year mortality
Figure 4 demonstrates the relationships of postdialysis
BP and the fall in BP upon standing soon after hemodial-
ysis with death. A greater fall in SBP and DBP upon
standing soon after hemodialysis from the supine value
measured after hemodialysis was associated with in-
creased mortality for all the BP ranges except the SBP
range 140 to 149 mm Hg and DBP range 70 to 79 mm Hg.
This relationship was most clearly demonstrated when
the cut-off point for the fall in SBP was set at 40 mm Hg
(40 mm Hg or greater versus less than 39 mm Hg), as
was when the cut-off point for the fall in DBP was set at
10 mm Hg (10 mm Hg or larger versus less than
9 mm Hg).
We examined the relationship between BP upon stand-
ing soon after hemodialysis and mortality using multi-
variate logistic regression analysis (Table 4). After ad-
justment for known prognostic factors, the odds ratio for
SBP lower than 99 mm Hg and that between 120 and
129 mm Hg remained significantly associated with mor-
tality. However, after adjustment for known prognostic
factors, the odds ratio for DBP was not significant. After
precluding accidental death unrelated to hemodialysis or
uremia, both the odds ratios for SBP and that for DBP
were no longer significant. To analyze the impact of or-
thostatic hypotension occurring soon after hemodialysis
on cardiovascular and cerebrovascular disease, we exam-
ined the relationship between the BP upon standing soon
after hemodialysis and cardio/cerebrovascular death rate
using multivariate logistic regression analysis. As shown
in Table 4, there was no significant relationship.
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Table 4. Odds ratios for two-year mortality associated with hemodialysis-associated hypotension
Total death Total death precluding accident Cardio/cerebrovascular death
Adjusted odds ratioa (95% Cl) P valueb Adjusted odds ratioa (95% Cl) P valueb Adjusted odds ratioa (95% Cl) P valueb
Lowest intradialysis SBP
<109 2.45 (0.95–6.28) 2.30 (0.89–5.95) 1.86 (0.67–5.17)
110–119 3.03 (1.14–8.04) b 3.04 (1.14–8.07) b 1.50 (0.47–4.71)
120–129 2.44 (0.98–6.11) 2.31 (0.92–5.82) 1.20 (0.41–3.52)
130–139 Reference Reference Reference
140–149 1.42 (0.50–3.98) 1.43 (0.51–4.03) 0.81 (0.24–2.78)
>150 1.65 (0.61–4.42) 1.67 (0.62–4.48) 1.50 (0.52–4.35)
Lowest intradialysis DBP
<59 2.62 (1.08–6.40) b 2.59 (1.06–6.32) b 3.11 (1.14–8.45) b
60–69 1.31 (0.69–2.48) 1.31 (0.69–2.48) 1.16 (0.52–2.58)
70–79 Reference Reference Reference
80–89 1.60 (0.77–3.34) 1.38 (0.64–2.96) 1.57 (0.64–3.86)
90–99 2.30 (0.76–6.97) 2.23 (0.75–6.94) 1.99 (0.51–7.71)
>100 3.44 (0.37–32.06) 3.44 (0.37–32.10) 4.21 (0.46–38.80)
SBP upon standing soon after hemodialysis
<99 2.47 (1.11–5.49) b 2.20 (0.97–4.98) 2.24 (0.86–5.84)
100–109 1.33 (0.49–3.64) 1.35 (0.49–3.68) 1.10 (0.31–3.86)
110–119 2.03 (0.83–4.96) 2.03 (0.83–4.98) 1.25 (0.38–4.04)
120–129 2.26 (1.00–5.09) b 2.24 (0.99–5.06) 1.72 (0.61–4.84)
130–139 1.10 (0.45–2.69) 1.09 (0.44–2.68) 1.22 (0.42–3.52)
140–149 0.96 (0.35–2.60) 0.94 (0.35–2.57) 0.88 (0.25–3.08)
>150 Reference Reference Reference
DBP upon standing soon after hemodialysis
<59 1.86 (0.52–6.62) 1.64 (0.45–5.95) 5.67 (0.68–47.55)
60–69 1.90 (0.61–5.89) 1.82 (0.58–5.65) 3.31 (0.41–26.50)
70–79 1.59 (0.51–4.96) 1.57 (0.50–4.90) 3.71 (0.47–29.20)
80–89 1.02 (0.30–3.42) 1.00 (0.30–3.38) 2.44 (0.29–20.34)
90–99 Reference Reference Reference
>100 2.27 (0.51–10.09) 2.26 (0.51–10.06) 6.14 (0.61–61.87)
Abbreviations are: SBP, systolic blood pressure; DBP, diastolic blood pressure. Multivariate logistic regression model is adjusted for age, gender, diabetic status,
serum creatinine, ultrafiltration per body weight, and body weight after hemodialysis. Reference, the BP associated with the lowest mortality was selected as the
reference value, and assigned an odds ratio of 1.0.
aOdds ratios greater than 1 imply higher mortality rates, while odds ratios less than 1 imply lower mortality rates.
bP value < 0.05.
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Fig. 4. Two-year mortality for various ranges
of postdialysis blood pressure (BP) and fall
in BP upon standing soon after hemodialy-
sis. Within each range of post-dialysis BP, the
columns indicate two-year mortality associ-
ated with fall in BP upon standing soon af-
ter hemodialysis from the supine value mea-
sured after hemodialysis in two groups. Cut-
offs for grouping are defined at the top of (A)
and (B). (A) shows systolic blood pressure
(SBP) and (B) shows diastolic blood pressure
(DBP). A greater fall in BP upon standing
soon after hemodialysis is associated with in-
creased mortality in all ranges of postdialysis
BP except the SBP range 140–149 mm Hg and
DBP range 70–79 mm Hg.
Predictors of mortality using the multivariate
logistic regression model
To further examine the relationships of intradialy-
sis hypotension and orthostatic hypotension occurring
soon after hemodialysis with mortality, we constructed
a multivariate logistic regression model (Table 5). After
adjustment for known prognostic factors, the lowest in-
tradialysis SBP and the fall in SBP upon standing soon
after hemodialysis from the supine value measured af-
ter hemodialysis were significant and independent risk
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Table 5. Odds ratios from multivariate logistic regression analysis for
two-year mortality associated with intradialysis hypotension and
postdialysis orthostatic hypotension
Odds ratio (95% CI) P value
Lowest intradialysis SBP 0.79 (0.64–0.98) 0.033
(by 20 mm Hg increments)
Fall in SBP on standing 0.82 (0.67–0.98) 0.046
soon after hemodialysis
(by 10 mm Hg increments)
Multivariate logistic regression model is adjusted for age, gender, diabetic
status, serum creatinine, ultrafiltration per body weight, and body weight after
hemodialysis.
factors for two-year mortality. The adjusted odds ratio
for death was 0.79 (95% CI 0.64–0.98) when the lowest
intradialysis SBP was analyzed in increments of 20 mm
Hg, and was 0.82 (95% CI 0.67–0.98) when the decline in
SBP upon standing after dialysis was analyzed in incre-
ments of 10 mm Hg.
The impact of diabetes mellitus
We examined the impact of hemodialysis-associated
hypotension on mortality separately in diabetic patients
(N = 260) and in nondiabetic patients (N = 946), as
shown in Table 6. In diabetic dialysis patients, the low-
est intradialysis SBP and the SBP upon standing soon af-
ter hemodialysis were not significant predictors of death
in multivariate analysis. In nondiabetic dialysis patients,
both the lowest intradialysis SBP and the SBP upon
standing soon after hemodialysis were significant predic-
tors of death in multivariate analysis.
The influence of antihypertensive or
antihypotensive medications
We examined the influence of antihypertensive or an-
tihypotensive medications on the relationship between
hemodialysis-associated hypotension and mortality
(Table 6).
Of all patients, 36% were prescribed one antihyper-
tensive medication, 31% more than two medications,
and 33% no antihypertensive medication. Antihyperten-
sive medications in use included calcium channel blocker
(48%), angiotensin-converting enzyme inhibitor (17%),
a-blocker (12%), b-blocker (9%), angiotensin receptor
blocker (6%), and others. In patients using antihyper-
tensive medications, the lowest intradialysis SBP was a
significant predictor of death only in univariate analysis.
In patients not using antihypertensive medications, the
fall in SBP during hemodialysis was a predictor of death
only in univariate analysis.
Of all patients, 10% were prescribed one antihypoten-
sive medication, 1% more than two medications, and 89%
no antihypotensive medication. Antihypotensive medi-
cations in use included amezinium metilsulfate, droxi-
dopa, midodrine hydrochloride, etilefrine hydrochloride,
and others. In patients using antihypotensive medica-
tions, the lowest intradialysis SBP was a significant pre-
dictor of death by multivariate analysis. In patients not
using antihypotensive medications, the lowest intradial-
ysis SBP was a significant predictor of death only in uni-
variate analysis.
Pulse pressure and two-year mortality
Univariate logistic regression analysis was used to ex-
amine the relationship between pulse pressure and mor-
tality. Pulse pressure did not relate significantly with
two-year mortality. To further examine the relationships
between pulse pressure and mortality, we constructed a
multivariate logistic regression model. After adjustment
for known prognostic factors, pulse pressure also showed
no significant relationship with two-year mortality.
DISCUSSION
The results of our multicenter prospective, observa-
tional cohort study that included 1244 Japanese patients
with a follow-up period of two years indicated an asso-
ciation between increased mortality and hemodialysis-
associated hypotension. Specifically, we found that the
lowest intradialysis SBP and the fall in SBP upon standing
soon after hemodialysis from the supine value measured
after hemodialysis were significant and independent risk
factors for two-year mortality after adjustment for known
prognostic factors.
Previous investigators have pointed out that intradial-
ysis hypotension not only causes discomfort, but also may
increase mortality [6, 10]. Evidence supporting this view
is sparse. Koch and Ritz et al [8, 11] reported that the
risk of cardiac death was increased when two or three
hypotensive episodes occurred per week, but their rel-
atively small study failed to show significant differences
in BP during hemodialysis between patients who died
of myocardial infarction and survivors. In our series of
1244 hemodialysis patients, by univariate analysis, we
also found no significant differences in the fall in BP
from the supine value before hemodialysis to the low-
est intradialysis value or in the fall in BP upon stand-
ing soon after hemodialysis from the supine value mea-
sured after hemodialysis; however, we found that the
lowest intradialysis SBP and the fall in SBP upon stand-
ing soon after hemodialysis from the supine value mea-
sured after hemodialysis were significant and indepen-
dent risk factors of two-year mortality after adjustment
for confounders. It is likely that hemodialysis-associated
hypotension could damage vital organs, such as the brain
or heart. A previous study [12] showed that hemodialysis-
associated hypotension caused severe orthostatic reduc-
tion in cerebral blood flow velocity. Rapid progression
Shoji et al: Hemodialysis-associated hypotension and mortality 1219
Table 6. Odd ratios for two-year mortality associated with hemodialysis-associated hypotension and confounding factors
Diabetes Antihypertensives Antihypotensives
Total death DM Non-DM With Without With Without
Lowest intradialysis SBP
Low vs. high
Unadjusteda 1.77 (1.23–2.56)c 1.92 (0.97–3.81) 2.23 (1.37–3.63)b 2.12 (1.29–3.48)b 1.29 (0.74–2.25) 1.36 (0.50–3.68) 1.57 (1.04–2.35)b
Adjusteda 1.90 (1.16–3.11)b 1.76 (0.79–3.90) 2.06 (1.09–3.88)b 1.72 (0.85–3.48) 1.80 (0.87–3.72) 6.35 (1.20–33.53)b 1.46 (0.86–2.50)
Fall in SBP during HD
Large vs. small
Unadjusteda 1.46 (1.01–2.13)b 0.76 (0.37–1.54) 2.22 (1.38–3.58)b 1.64 (0.81–3.34) 1.81 (1.06–3.09)b 1.09 (0.49–2.39) 1.44 (0.94–2.21)
Adjusteda 1.50 (0.90–2.48) 0.83 (0.36–1.90) 1.87 (0.98–3.59) 1.12 (0.51–2.45) 1.97 (1.00–3.87) 1.10 (0.36–3.36) 1.41 (0.79–2.51)
SBP on standing soon after HD
Low vs. high
Unadjusteda 1.32 (0.93–1.89) 1.12 (0.58–2.19) 1.69 (1.06–2.69)b 1.56 (0.96–2.55) 1.00 (0.59–1.70) 1.07 (0.49–2.57) 1.18 (0.79–1.76)
Adjusteda 2.02 (1.17–3.32)c 1.27 (0.58–2.81) 2.47 (1.29–4.73)c 1.93 (0.95–3.91) 1.60 (0.80–3.21) 7.03 (0.81–61.11) 1.41 (0.82–2.40)
Fall in SBP on standing soon after HD
Large vs. small
Unadjusteda 1.26 (0.81–1.95) 0.88 (0.42–1.86) 1.31 (0.72–2.38) 1.93 (0.95–3.90) 1.10 (0.55–2.20) 0.70 (0.28–1.80) 1.36 (0.83–2.25)
Adjusteda 1.47 (0.85–2.53) 0.90 (0.38–2.13) 1.74 (0.84–3.63) 1.63 (0.77–3.46) 1.52 (0.69–3.37) 1.26 (0.38–4.22) 1.43 (0.76–2.68)
Intradialytic lowest SBP and SBP on standing soon after HD were categorized into low (<129 mm Hg) and high (129 mm Hg or higher). Fall in SBP during HD and
on standing soon after HD were categorized into large (40 mm Hg or larger) and small (<40 mm Hg). Multivariate logistic regression model is adjusted for age, gender,
diabetic status, serum creatinine, ultrafiltration per body weight, and body weight after hemodialysis.
aOdds ratios greater than 1 imply higher mortality rates, while odds ratios less than 1 imply lower mortality rates.
bP value < 0.05.
cP value < 0.01.
of brain atrophy was also shown to be related to asymp-
tomatic ischemic brain lesions in hemodialysis patients
[13]. Although the present data could not fully support
the possibility that hemodialysis-associated hypotension
could cause hemodynamically mediated brain damage,
this is a topic of considerable interest.
The relationship between BP and survival in hemodial-
ysis patients has remained quite controversial. Some stud-
ies suggest poorer outcome in patients with uncontrolled
hypertension [2], while, in contrast, recent studies show
that lower BP before hemodialysis is associated with ex-
cess mortality [3–5]. One potential confounding factor
may be hemodialysis-associated hypotension [6, 7]. Our
study showed a significant association between the low-
est intradialysis SBP and two-year mortality. As shown
in Figure 2, the lowest intradialysis BP and the BP before
hemodialysis were independently associated with two-
year mortality. We found that the impact of the intradialy-
sis fall in SBP on mortality was independent of predialysis
SBP. In contrast, BP before hemodialysis was not a signif-
icant risk factor for two-year mortality when analyzed by
the multivariate logistic regression model in our cohort.
Other investigators recently reported that pulse pressure
was a predictor of mortality [14, 15], but pulse pressure
was not a significant risk factor of two-year mortality in
our cohort. These inconsistencies may be explained by
differences in case series, dialysis adequacy, or the medi-
cal or social background of the subjects.
We also evaluated the influence of primary disease and
use of antihypertensive and antihypotensive medications
on the relationship between hemodialysis-associated hy-
potension and mortality. We found that the fall in intra-
or postdialysis BP in diabetic patients was significantly
greater than in nondiabetic patients. However, in dia-
betic dialysis patients, the lowest intradialysis SBP and
the SBP upon standing soon after hemodialysis from the
supine value measured after hemodialysis were not sig-
nificant multivariate predictors of death. On the other
hand, in nondiabetic dialysis patients, both the lowest
intradialysis SBP and the SBP upon standing soon af-
ter hemodialysis from the supine value measured after
hemodialysis were significant multivariate predictors of
death. The reason why hemodialysis hypotension was not
a significant predictor of death in diabetic patients is un-
clear. The number of diabetic patients was 260, which
may be insufficient to detect the impact of hemodialysis
hypotension on mortality. In patients using and not using
antihypertensive medications, hemodialysis hypotension
tended to increase mortality, but the odds ratios were
not significant in multivariate analysis. In patients using
antihypotensive medications, hemodialysis hypotension
remained a significant predictor for mortality in multi-
variate analysis.
It is known that the major causes of hemodialysis-
associated hypotension include an impaired sympathetic
response, old age, atherosclerosis, poor cardiac reserve
[16], and removal of vast volume of fluid. Specifically,
in our 1244 hemodialysis patients, we found a signifi-
cant correlation between a fall in intra- or postdialysis
BP and the duration of hemodialysis, decrease in body
weight during hemodialysis, ultrafiltration adjusted for
body weight, dBV, or serum albumin. We could not eval-
uate the relationship between hemodialysis-associated
hypotension and the adequacy of dry weight setting,
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impaired sympathetic response, atherosclerosis, or car-
diac function (e.g., ECG findings) because of limitations
of the study protocol; we did not evaluate these param-
eters at entry of the patients. A criticism of this study
may be the suggestion that hemodialysis-associated hy-
potension is not a causative factor for the poor progno-
sis, but merely a consequence of those above-mentioned
poor prognostic factors. Unfortunately, this observational
study was unable to evaluate this possibility. However,
such criticism would tend to underestimate the impact
of hemodynamically mediated organ damage [12, 13].
A further interventional study is necessary to deter-
mine whether preventing hemodialysis-associated hy-
potension will improve the prognosis of hemodialysis
patients.
CONCLUSION
To the best of our knowledge, this study pro-
vides the first evidence that hemodialysis-associated hy-
potension increases mortality in hemodialysis patients.
Hemodialysis-associated hypotension remains one of
the main complications of hemodialysis [17]. Prevention
of hemodialysis-associated hypotension is an important
challenge to the nephrologist.
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